1. A4.11 Syndecan-4 is an important player in regulating the WNT signalling pathway in articular cartilage. (13th February 2015) Authors: Clarke, C; Held, A; Stange, R; Nalesso, G; Sherwood, J; Hansen, U; Godmann, L; Echtermeyer, F; Dell'Accio, F; Pap, T; Bertrand, J Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A4.22 Syndecan-4 controls interleukin (IL)-1 receptor trafficking and IL-1 signalling in chronic destructive arthritis. (13th February 2015) Authors: Godmann, L; König, U; Stratis, A; Cromme, C; Neugebauer, K; Herzog, C; Korb-Pap, A; Niederreiter, B; Dankbar, B; Redlich, K; Echtermeyer, F; Pap, T; Bertrand, J Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Protective role of syndecan-4 in experimental colitis. (22nd February 2012) Authors: Stratis, A; Bettenworth, D; Neugebauer, K; Fröhling, M; Paruzel, P; Dankbar, B; Wemeyer, ; Cromme, C; Godmann, L; Bertrand, J; Korb, A; Echtermeyer, F; Kollias, G; Lügering, A; Pap, T Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 1 Page Start: A76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗